Effect of high-dose DPP-4 inhibitor or single-dose rapid-acting insulin on glycemic control in type 2 diabetic patients treated with regular-dose DPP-4 inhibitor and long-acting insulin

Trial Profile

Effect of high-dose DPP-4 inhibitor or single-dose rapid-acting insulin on glycemic control in type 2 diabetic patients treated with regular-dose DPP-4 inhibitor and long-acting insulin

Completed
Phase of Trial: Phase II

Latest Information Update: 25 Oct 2013

At a glance

  • Drugs Insulin glulisine (Primary) ; Sitagliptin (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Pharmacodynamics
  • Most Recent Events

    • 25 Oct 2013 Status changed from active, no longer recruiting to completed as reported by University Hospital Medical Information Network - Japan record.
    • 30 Jul 2013 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan record.
    • 03 Apr 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top